Constantine, Robert, PhD
Robert Constantine, PhD, MPH is a Research Associate Professor in the Department of Mental Health Law and Policy at the Louis De La Parte Florida Mental Health Institute, University of South Florida. He received a Ph.D. in Sociology from Florida State University and more recently a Masters in Public Health from the University of Connecticut. During his more than 30 years in the mental health field, Constantine managed behavioral health care services at a wide variety of levels. His early years were spent in Florida's Department of Health and Rehabilitative Services where he managed a state forensic hospital, served as the Director of Mental Health and Substance Abuse Services on two different occasions and as District Administrator responsible for all state-supported health and human services in southwest Florida. Following state service Dr. Constantine spent a decade working for a hospital corporation, first as a hospital administrator and ultimately as a senior vice president responsible for 12 hospitals. More recently Constantine served as the CEO of the Florida Council for Behavioral Healthcare, a trade association of community-based behavioral health care providers. In this capacity, he helped frame state policy and advocated for the resources needed to improve the performance of Florida's mental health system. Dr. Constantine moved to the Florida Mental Health Institute in May of 2004. Since that time he has served as principle investigator for a number of research projects including a managed care evaluation, a study of the adults with a serious mental illness who became involved in the criminal justice system, a study of children with emotional disturbances as they transitioned to adulthood and a follow-up study of children under 6 years old who went through a prior authorization process for the of antipsychotic medications. In addition, he served as principal investigator for the Behavioral Pharmacy Management Program and the Medicaid Drug Therapy Management Program for Behavioral Health (MDTMP). The latter two projects were multi-million dollar studies/interventions funded by the pharmaceutical industry and the State of Florida respectively. He continues to serve as the principal investigator for the MDTMP and for a clinical trial of the effectiveness of 2 vs. 1 antipsychotic medications in the treatment of patients with schizophrenia.
- University of Connecticut, MPH, 1994
- Florida State University, Ph.D., 1976
- Kent State University, M.A., 1974
- Iona College, B.A., 1968
- Evidence-based psychopharmacology
- Criminal justice involvements of individuals with mental illness
- Medical care quality improvement
- AHCA - Evaluation of Florida’s Medicaid Managed Mental Health Plans: Administrative Data Sub-study
- AHCA Administrative Data Component
- Data Services-Behavioral Health Partnership
- Florida Behavioral Pharmacy Management Program
- Healthcare Resources Among Individuals Receiving Different Anti-Psychotic Medications
- Impact of Consta Related Preferred Drug List Changes on Patient Outcomes and Costs to the Healthcare System
- Impact of Restricted Drug List Policy on Health Outcomes and Cost
- Medicaid Drug Therapy Management System for Behavioral Health
- Pilot Study on Baker Act Evaluations and Associated C5U and Hospital Discharges Receiving RLAI
Constantine, R., Robst, J., Andel, R., & Teague, G. (in press). The impact of
mental health services on arrests of offenders with a serious mental illness. Law and Human Behavior, Advanced online publication. doi: 10.1007/s10979-011-9276-2
Becker, M. A., Andel, R., Boaz, T., & Constantine, R. (2011). Gender differences and risk of arrest among offenders with serious mental illness. The Journal of Behavioral Health Services and Research, 38(1), 16-28.
Boaz, T. L., Constantine, R., Robst, J., Becker, M. A., & Howe, A. M. (2011). Risperidone long-acting therapy prescribing patterns and their impact on early discontinuation of treatment in a large medicaid population. The Journal of Clinical Psychiatry, 72(8), 1079-1085.
Constantine, R., Tandon, R., McPherson, M., & Andel, R. (2011). Early diagnoses and psychotherapeutic medication treatment experiences of a cohort of children under six years old who received antipsychotic treatment in Florida's Medicaid program. Journal of Child and Adolescent Psychopharmacology, 21(1), 79-84.
Constantine, R., Andel, R., & Tandon, R. (2010). Trends in adult antipsychotic polypharmacy: Progress and challenges in Florida’s Medicaid. Community Mental Health Journal, 46(6), 523-530.
Constantine, R., Boaz, T., & Tandon, R. (2010). Antipsychotic polypharmacy in the treatment of children and adolescents in the fee for service component of a large state Medicaid program. Clinical Therapeutics, 32, 949-959.
Constantine, R., Andel, R., Petrila, J., Becker, M., Robst, J., Teague, G., et al. (2010). Characteristics and experiences of adults with a serious mental illness who were involved in the criminal justice system. Psychiatric Services, 61(5), 451-468.
Constantine, R., Petrila, J., Andel, R., Givens, E. M., Becker, M., Robst, J., et al. (2010). Arrest trajectories of adult offenders with a serious mental illness. Psychology, Public Policy, and Law, 16(4), 319-339.
Petrila, J., Andel, R., Constantine, R., & Robst, J. (2010). Public expenditures related to the criminal justice system and to services for arrestees with a serious mental illness. Psychiatric Services, 61(5), 516-519.
Robst, J., Constantine, R., Boaz, T., Andel, R., Teague, G., Becker, M., et al. (2010). Short-term impact of preferred drug list changes on health care use and Medicaid costs: Injectable Risperidone. Psychiatric Services, 61(9), 937-939.